Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing
In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value
Backed by robust profitability, HOLX deploys billions into acquisitions and repurchases to boost future earnings.
HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now?
As demand for GYN surgical tools climbs, HOLX and COO battle it out. Find out which stock shows stronger growth momentum now.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights
Hologic (HOLX) concluded the recent trading session at $64.14, signifying a -1.6% move from its prior day's close.
Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence?
HOLX lifts margins despite tariffs and weak China sales, leaning on diagnostics strength and high-margin buys.
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?
HOLX grapples with global headwinds, but growth in Diagnostics and Breast Health service lifts confidence.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic Climbs 13% in a Month: How Should You Play the Stock?
After lagging for months, Hologic HOLX has picked up momentum in recent weeks. Shares of the Marlborough, MA-based company have climbed 13.3% over the past month, higher than the industry and the broader Medical sector's gains of 2.4% and 3.4%, respectively.
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?
HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
